Synonyms: ATI-501 | ATI50001 | ATI501 | example 103 [WO2007070872A1]
Compound class:
Synthetic organic
Comment: ATI-50001 (ATI-501) is an orally bioactive kinase inhibitor, with selectivity for Janus kinases (JAK) 1/3. It was claimed in Rigel Pharmaceuticals' 2007 patent WO2007070872A1 [1], but it was later developed by Aclaris Therapeutics.
|
|
Bioactivity Comments |
Patent WO2007070872A1 provides a generalised IC50 value of <1 μM for this compound vs. Janus kinases, but does not give more precise data for individual JAK subtypes [1]. |